Technology is available through distribution partnership with Al Faisaliah Medical Systems Co. Ltd.
ST. PAUL, Minn., Sunday, December 12th 2010 [ME NewsWire]:
(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first time availability of their neurostimulation systems in Saudi Arabia. Offered through an exclusive distribution partnership with Al Faisaliah Medical Systems Co. Ltd., this alliance provides physicians in Saudi Arabia with access to the full line of St. Jude Medical spinal cord stimulation (SCS) and deep brain stimulation (DBS) systems.
Neurostimulators deliver small, precise doses of electricity to targeted parts of the body to block pain or restore function. The systems consist of an implanted device that is similar in size and function to a cardiac pacemaker, along with electrical leads and a programmer that allow clinicians to customize the system to each patient.
“For more than 30 years we have developed innovative new neurostimulation products, and we have worked diligently to broaden the availability of these systems,” said Chris Chavez, president of the St. Jude Medical Neuromodulation Division. “We are pleased to be able to partner with Al Faisaliah Medical Systems Co. Ltd. to bring our products to physicians and patients in Saudi Arabia.”
“Our company strives to provide physicians with the best possible medical products for their patients,” said Ali Damati, executive general manager of Al Faisaliah Medical Systems Co. Ltd. “We are excited to work with St. Jude Medical, and the addition of neurostimulation systems represent an important area as we broaden our portfolio of products.”
St. Jude Medical spinal cord stimulators are approved for the management of chronic pain of the trunk and limbs or pain from back surgeries that have failed. Often referred to as a “pacemaker for pain,” these devices send small pulses of electricity to specific nerve fibers along the spinal cord to interrupt or mask the transmission of pain signals to the brain. The company’s deep brain stimulators are approved for managing the symptoms of Parkinson’s disease. DBS systems deliver small doses of electricity to targeted parts of the brain to interrupt abnormal brain signals and restore function.
Key products that are available include:
* Eon Mini™ spinal cord stimulator – the world’s smallest, longest-lasting rechargeable neurostimulation device for the management of chronic pain
* Eon™ spinal cord stimulator – the highest capacity rechargeable battery on the market for the management of chronic pain, the device can provide sustainable therapy and maintain a reasonable recharge interval for 10 years
* Epiducer™ lead delivery system – exclusive design allows introduction of S-Series™ perc-paddle leads as well as multiple lead arrays utilized in SCS therapy through a single percutaneous entry
* Penta™ surgical lead – a first-of-its-kind, five-column surgical lead featuring the smallest electrodes on the market
* Brio™ deep brain stimulator – the world’s smallest, longest-lasting rechargeable neurostimulator for managing the symptoms of Parkinson’s disease
* Libra™ and LibraXP™ deep brain stimulators – constant current devices that feature the largest battery capacity of any DBS device in their class, which may maximize the time between device replacement procedures
For more than 30 years, the St. Jude Medical Neuromodulation Division has developed new technologies to manage chronic pain and other neurological disorders. Today more than 75,000 patients in 40 countries have been implanted with St. Jude Medical neurostimulation systems.
About St. Jude Medical
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minn. and has four major focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com.
About Al Faisaliah Medical Systems Co. Ltd
Founded in 1975, Al Faisaliah Medical Systems (FMS) is one of the Middle East’s largest medical devices and services companies. Headquartered in Riyadh, Saudi Arabia, FMS conducts business in more than six countries in the Middle East. With more than 600 employees regionwide and business partnerships with best-in-class companies in the field of healthcare technologies, today FMS is a major player in providing diversified healthcare solutions, systems and related consumables and services to the leading hospitals and institutions in Saudi Arabia and the Middle East. For more information, please visit www.alfaisaliah-medical.com.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended October 2, 2010. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.
For media enquiries, please contact:
St. Jude Medical, Inc.
J.C. Weigelt
Investor Relations
651-756-4347
jweigelt@sjm.com
Denise Landry
Media Relations
972-309-8085
dlandry@sjm.com
No comments:
Post a Comment